Strong half year revenues reported by prenatal testing group
Manchester biotech company Premaitha Health reported strong sales in the six months to September 30, today.
The AIM-listed firm, which provides non-invasive prenatal testing, issued a half year trading update ahead of its annual general meeting on October 25, and the release of its interim figures on, or before, December 3.
Today's statement said first half revenues were approximately £3.9m, which was an increase of 45% on the corresponding period last year.
It said it has also made a strong start to the second half of the f... For the full story register now for free or login below...